GOLDMAN SACHS GROUP INC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,723,371
-17.6%
255,368
-7.2%
0.00%0.0%
Q2 2023$10,590,580
+3.7%
275,080
-3.6%
0.00%0.0%
Q1 2023$10,215,289
-8.6%
285,423
+0.7%
0.00%
-33.3%
Q4 2022$11,180,022
-33.4%
283,541
-39.1%
0.00%
-25.0%
Q3 2022$16,796,000
+86.3%
465,265
+57.0%
0.00%
+100.0%
Q2 2022$9,014,000
-59.3%
296,314
-59.1%
0.00%
-60.0%
Q1 2022$22,143,000
+313.6%
724,337
+322.6%
0.01%
+400.0%
Q4 2021$5,354,000
+265.0%
171,394
+78.6%
0.00%
Q3 2021$1,467,000
-48.2%
95,985
-36.9%
0.00%
-100.0%
Q2 2021$2,834,000
+17.1%
152,218
+12.6%
0.00%0.0%
Q1 2021$2,420,000
+14.0%
135,219
-2.0%
0.00%0.0%
Q4 2020$2,122,000
+209.3%
137,961
+122.6%
0.00%
Q3 2020$686,000
+86.9%
61,966
+111.7%
0.00%
Q2 2020$367,000
+115.9%
29,272
+126.3%
0.00%
Q4 2019$170,000
+78.9%
12,937
+22.9%
0.00%
Q3 2019$95,000
-23.4%
10,529
-14.0%
0.00%
Q1 2019$124,000
+55.0%
12,246
-3.3%
0.00%
Q4 2018$80,000
-60.4%
12,663
+5.5%
0.00%
Q1 2015$202,000
-50.9%
11,999
-42.3%
0.00%
Q4 2014$411,00020,8000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders